Dashboard
Manage Tickers

CVM


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cel-sci-to-present-data-for-multikine-head--neck-cancer-immunotherapy-at-esmo-2024-congress
CEL-SCI To Present Data for Multikine Head...
09/10/2024 13:33:35

the-uks-mhra-grants-cel-scis-multikine-a-product-specific-waiver-for-the-treatment-of-head-and-neck-cancer-in-a-pediatric-population-of-people-up-to-18-years-of-age
The UK's MHRA Grants CEL-SCI's Multikine A...
09/04/2024 13:03:00

CEL-SCI Corporation (NYSE:CVM) today reported it has received a decision letter from the United Kingdom's Healthcare Produc...

cel-sci-q3-2024-adj-eps-014-misses-011-estimate
CEL-SCI Q3 2024 Adj EPS $(0.14) Misses $(0...
08/15/2024 12:04:16

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.11) by 27....

why-saia-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Saia Shares Are Trading Lower? Here Ar...
07/26/2024 17:25:58

cel-sci-shares-resume-trade
CEL-SCI Shares Resume Trade
07/26/2024 16:15:25

cel-sci-shares-halted-on-code-news-pending
CEL-SCI Shares Halted On Code News Pending
07/26/2024 15:59:52

cel-sci-prices-10845m-best-efforts-offering-of-10845m-shares-and-pre-funded-warrants-at-a-price-of-1share
CEL-SCI Prices $10.845M Best-Efforts Offer...
07/26/2024 15:52:51

CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE: CVM), a cancer immunotherapy company, today announced t...

cel-sci-shares-are-trading-higher-after-the-company-announced-results-from-a-bias-analysis-conducted-for-its-concluded-phase-3-study-of-multikine-multikine-cut-the-5-year-risk-of-death-by-half-compared-to-control-in-its-target-population
CEL-SCI shares are trading higher after th...
07/26/2024 12:29:22

cel-scis-phase-3-population-analysis-for-confirmatory-registration-study-in-head--neck-cancer-demonstrates-well-balanced-patient-population-confidence-in-clinical-results-multikine-a-cancer-immunotherapy-cut-the-5-year-risk-of-death-by-half-compared-to-control-in-its-target-population
CEL-SCI's Phase 3 Population Analysis For ...
07/26/2024 12:24:33

Multikine, a true first-line cancer immunotherapy, cut the 5-year risk of death by half compared to control in its target popul...

cel-sci-appoints-robert-watson-as-chairperson-of-the-board
CEL-SCI Appoints Robert Watson As Chairper...
07/08/2024 13:21:33

CEL-SCI Corporation (NYSE:CVM) today announced that Robert ("Bob") Watson, who has served as a Director of the Company ...

cel-sci-presents-head--neck-cancer-data-at-iddst-annual-congress-in-budapest-risk-of-death-cut-in-half-for-patients-treated-with-multikine-in-the-target-population
CEL-SCI Presents Head & Neck Cancer Data A...
06/18/2024 12:21:27

Multikine significantly increases overall survival in patients with low levels of tumor cell PD-L1 expression in contrast to ap...

cel-sci-q2-2024-gaap-eps-028-misses-014-estimate
CEL-SCI Q2 2024 GAAP EPS $(0.28) Misses $(...
05/16/2024 13:06:11

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.14) by 100...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

why-cel-sci-cvm-shares-are-trading-higher
Why CEL-SCI (CVM) Shares Are Trading Higher
05/08/2024 15:19:20

CEL-SCI shares are trading higher by 18.6% during Wednesday's session. The company received positive feedback from the FDA ...

cel-sci-shares-are-trading-higher-after-the-company-announced-it-received-fda-approval-for-its-confirmatory-study-of-multikine-for-the-treatment-of-head--neck-cancer
CEL-SCI shares are trading higher after th...
05/08/2024 15:19:02

cel-sci-receives-fda-approval-for-its-confirmatory-study-of-multikine-for-the-treatment-of-head--neck-cancer
CEL-SCI Receives FDA Approval For Its Conf...
05/08/2024 13:03:58

Critical milestone achieved—the FDA accepted CEL-SCI's selection criteria defining the Multikine target population before s...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

cel-sci-corporation-issues-letter-to-shareholders
CEL-SCI Corporation Issues Letter To Share...
03/06/2024 13:47:33

CEL-SCI Corporation (NYSE:CVM) today issued a letter to its shareholders. This letter will be sent to the Company's shareho...

cel-sci-q1-eps-014-up-from-018-yoy
CEL-SCI Q1 EPS $(0.14) Up From $(0.18) YoY
02/15/2024 13:12:43

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.14) per share. This is a 22.22 percent increase over losses of $(0.18) per ...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
02/09/2024 17:31:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION